(Q35028046)

5 August 2017

title

Alternative pathways of angiotensin II production in the human saphenous vein (English)

1 reference

5 August 2017

Borland JA

1

1 reference

5 August 2017

Chester AH

series ordinal

2

1 reference

5 August 2017

Morrison KA

series ordinal

3

1 reference

5 August 2017

Yacoub MH

series ordinal

4

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 October 1998

1 reference

British Journal of Pharmacology

5 August 2017

published in

1 reference

5 August 2017

volume

125

1 reference

5 August 2017

issue

3

1 reference

5 August 2017

page(s)

423-428

1 reference

Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702018

Endothelial renin-angiotensin pathway: evidence for intracellular synthesis and secretion of angiotensins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702018

Tissue angiotensin II system in the human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702018

Arterial intimal hyperplasia after occlusion of the adventitial vasa vasorum in the pig

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702018

7 January 2021

Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702018

7 January 2021

Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702018

7 January 2021

Ramipril and experimental vein graft intimal hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702018

7 January 2021

Release of vasoactive substances during cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702018

7 January 2021

Multiple pathways of angiotensin production in the blood vessel wall: evidence, possibilities and hypotheses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702018

7 January 2021

Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702018

7 January 2021

Direct formation of angiotensin II without renin or converting enzyme in the ischemic dog heart

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702018

7 January 2021

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702018

7 January 2021

Arterial wall hypoxia following hyperfusion through the vasa vasorum is an initial lesion in atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702018

7 January 2021

Plasma angiotensins and blood pressure during converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702018

7 January 2021

Local generation and release of angiotensin II in peripheral vascular tissue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702018

7 January 2021

Chronic ACE Inhibition Reduces Intimal Hyperplasia in Experimental Vein Grafts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702018

7 January 2021

Different distribution of two types of angiotensin II-generating enzymes in the aortic wall

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702018

7 January 2021

Marked species-difference in the vascular angiotensin II-forming pathways: humans versus rodents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702018

7 January 2021

Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702018

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702018

7 January 2021

Angiotensin II-forming pathways in normal and failing human hearts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702018

7 January 2021

Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702018

7 January 2021

Angiotensin II formation in the intact human heart. Predominance of the angiotensin-converting enzyme pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702018

7 January 2021

Identifiers

DOI

10.1038/SJ.BJP.0702018

1 reference

5 August 2017

1 reference

5 August 2017

1 reference